ERBB2 and neoplasm: Model-simulated tumor growth curves under lapatinib and pyrotinib treatment can simultaneously match the experimental data from HER2+ cell line-derived mouse xenografts (CDX) [66, 67] (Fig. 5f, g and Supplementary Fig. S3a, b).